Yunnan Baiyao Group Co Ltd embodies a set of values and corporate philosophy that underpin their operations. Known for their commitment to quality, Yunnan Baiyao Group Co Ltd strives for excellence in all aspects of their business. They prioritize innovation, constantly seeking new ways to improve their products and services. With a strong focus on customer satisfaction, the company aims to meet and exceed the expectations of their stakeholders. Yunnan Baiyao Group Co Ltd also values integrity, transparency, and responsible corporate citizenship, ensuring ethical practices and fostering sustainable development. By promoting these values, the company positions itself as a trusted and respected player in the industry.

Yunnan Baiyao Group Co Ltd is primarily present in China.

Yunnan Baiyao Group Co Ltd, a leading Chinese pharmaceutical company, has achieved numerous significant milestones. The company, established in 1902, has a rich history of success. It became a listed company in 1993, marking an important breakthrough for Yunnan Baiyao. In 2006, the company was included in the Fortune China 500 list, a remarkable acknowledgment of its growth and prominence. Yunnan Baiyao Group Co Ltd also expanded its business internationally, entering markets in the United States, Europe, and Southeast Asia. Furthermore, the company has been recognized for its valuable contributions to the healthcare industry, earning accolades such as the National Quality Award and China's Time-honored Brand distinction.

Yunnan Baiyao Group Co Ltd, founded in 1902, is a renowned Chinese pharmaceutical company specializing in traditional Chinese medicine (TCM). With a rich history spanning over a century, Yunnan Baiyao has become a trusted brand known for its innovative healthcare products. The company originated in Yunnan Province and initially focused on producing and selling herbal medicines. Over time, it has grown into a global pharmaceutical enterprise, expanding its product portfolio to include not only TCM but also western medicines, healthcare products, and hospital services. Yunnan Baiyao Group Co Ltd's commitment to quality and research has earned it a strong reputation in the industry, making it an influential player in the healthcare sector.

The main competitors of Yunnan Baiyao Group Co Ltd in the market include Tong Ren Tang, China Resources Sanjiu Medical & Pharmaceutical Co Ltd, and Tasly Pharmaceutical Group. These companies operate in the same sector and offer similar products, leading to intense competition. Yunnan Baiyao Group Co Ltd has established its presence as a leading pharmaceutical company, known for its traditional Chinese medicine products and healthcare solutions. By constantly innovating and leveraging its strong brand reputation, Yunnan Baiyao Group Co Ltd strives to maintain a competitive edge in the market against these formidable rivals.

Yunnan Baiyao Group Co Ltd is primarily active in the pharmaceutical and healthcare industries.

The business model of Yunnan Baiyao Group Co Ltd, a Chinese pharmaceutical company, is primarily focused on the research, development, manufacturing, and sales of traditional Chinese medicines. Yunnan Baiyao Group Co Ltd primarily specializes in products such as Yunnan Baiyao, a well-known traditional Chinese medicine used for wound healing, as well as other healthcare products. The company's business model centers around providing high-quality and innovative traditional Chinese medicine products to customers. With a strong emphasis on research and development, Yunnan Baiyao Group Co Ltd aims to meet the diverse healthcare needs of consumers while continuously expanding its product portfolio and strengthening its market presence.

مُعامل القيمة السوقية إلى الأرباح لـ Yunnan Baiyao Group Co هو ١٨٫٧٦.

مُعامِل القيمة إلى المبيعات Yunnan Baiyao Group Co هو ٢٫٣١.

نقاط جودة AlleAktien لـ Yunnan Baiyao Group Co هي 6/10.

المتوقعة Yunnan Baiyao Group Co الإيرادات هي ٤٣٫١٦ مليارات CNY.

صافي الربح المتوقعة Yunnan Baiyao Group Co هو ٥٫٣٢ مليارات CNY.

The Yunnan Baiyao Group Co Ltd is a Chinese company specializing in the manufacturing and marketing of traditional Chinese medicines. It was founded in 1902 and is headquartered in Kunming, China. Its business model is focused on several sectors, including research and development, production and distribution of medicines, trade in medical devices, healthcare services, biotechnology, real estate development, and financial services. The company's main products are traditional Chinese medicines, with the Yunnan Baiyao plaster being its most well-known product. The company also produces other traditional Chinese medicines such as herbal extracts, capsules, and granules. In addition to medicine production, the company is involved in trading medical devices and products, offering a range of products such as surgical instruments, diagnostic equipment, and laboratory supplies. It has also established a business field for healthcare services, providing services in health management, medical care, and rehabilitation. The company has invested in biotechnology and owns a subsidiary focused on the development of biological medicines aimed at treating chronic diseases such as cancer and diabetes. It has also established a financial services subsidiary specializing in providing financial products and services, including asset management, insurance, and stock trading. In summary, the business model of Yunnan Baiyao Group Co Ltd is based on the production and sale of traditional Chinese medicines, trading in medical devices and products, healthcare services, biotechnology, and financial products and services. Despite diversification, the production and sale of traditional Chinese medicines remain the core of the business model.

يوزع Yunnan Baiyao Group Co أرباحًا قدرها ١٫١٤ CNY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Yunnan Baiyao Group Co في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـYunnan Baiyao Group Co هو CNE0000008X7.

رمز WKN لـ Yunnan Baiyao Group Co هو A0M3P2.

الرمز المُختصر لـ Yunnan Baiyao Group Co هو 000538.SZ.

خلال آخر 12 شهراً، دفعت Yunnan Baiyao Group Co توزيعات أرباح بقيمة ٣٫٢٩ CNY . وهذا يعادل عائد توزيعات أرباح يقارب ٥٫٨٩ %. ومن المتوقع أن تدفع Yunnan Baiyao Group Co خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٣٫٣٦ CNY.

نسبة توزيعات الأرباح الحالية لـ Yunnan Baiyao Group Co هي ٥٫٨٩ %.

Yunnan Baiyao Group Co يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يونيو, يونيو, ديسمبر, مايو.

Yunnan Baiyao Group Co دفعت توزيعات الأرباح كل عام خلال الـ23 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٣٫٣٦ CNY. وهذا يعادل عائد توزيعات أرباح قدره ٦٫٠٢ %.

Yunnan Baiyao Group Co يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ١٫١٨٥ CNY من Yunnan Baiyao Group Co المُعلن عنها في ٣٠‏/٤‏/٢٠٢٥، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٣٠‏/٤‏/٢٠٢٥.

تم توزيع آخر دفعة من الأرباح بتاريخ ٣٠‏/٤‏/٢٠٢٥.

في العام 2024، وزعت Yunnan Baiyao Group Co ١٫٥٢ CNY كأرباح أسهم.

يتم توزيع أرباح Yunnan Baiyao Group Co بالعملة CNY.